9SO.STU Solasia Pharma K.K

Oil, Gas & Consumable Fuels Stuttgart Exchange
0.1720 EUR
Close of Oct 21, 2026
0.0935 0.2200
Market cap
EUR 11.1M
P/E
-
P/B
2.94x
ROE
-79.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 9SO.STU undervalued?

Graham number

The Graham number of Solasia Pharma K.K cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Solasia Pharma K.K fundamental analysis

No fundamental analysis for Solasia Pharma K.K yet.

Solasia Pharma K.K stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Solasia Pharma K.K

Solasia Pharma K.K., a specialty pharmaceutical company, develops, imports/exports, and markets pharmaceutical products and medical devices, etc. in Japan. It offers SP-01 Sancuso, a transdermal delivery system that delivers the anti-emetic and granisetron into the patient"s bloodstream to patients receiving chemotherapy; and SP-02 Darinaparsin, a mitochondrial-targeted agent for the treatment of various hematologic and solid cancers, as well as SP-03 episil, an oral liquid …

Full company profile